1. Rivera C, Oliveira AK, Costa RAP, De Rossi T, Leme AFP. Prognostic biomarkers in oral squamous cell carcinoma: A systematic review. Oral Oncol. 2017;72:38-47.

https://doi.org/10.1016/j.oraloncology.2017.07.003

PMid:28797460 

2. Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884-94.

PMid:26617944

3. Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson DE, Edwards P, et al. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:650-69.

https://doi.org/10.1016/j.oooo.2018.03.012

PMid:29709496 

4. Scully C. Challenges in predicting which oral mucosal potentially malignant disease will progress to neoplasia. Oral Dis. 2014;20:1-5.

https://doi.org/10.1111/odi.12208

PMid:24320967 

5. Warnakulasuriya S. Oral potentially malignant disorders: A comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:104550.

https://doi.org/10.1016/j.oraloncology.2019.104550

PMid:31981993 

6. Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:582-90.

https://doi.org/10.1016/j.oooo.2018.03.011

PMid:29673799 

7. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:612-27.

https://doi.org/10.1016/j.oooo.2017.12.011

PMid:29396319 

8. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-74.

https://doi.org/10.1016/j.cell.2011.02.013

PMid:21376230 

9. Manasa VG, Kannan S. Impact of microRNA dynamics on cancer hallmarks: An oral cancer scenario. Tumour Biol. 2017;39:1010428317695920.

https://doi.org/10.1177/1010428317695920

PMid:28347239 

10. Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13:141-6.

https://doi.org/10.1097/XEB.0000000000000050

PMid:26134548 

11. Philipone E, Yoon AJ, Wang S, Shen J, Ko YC, Sink JM, et al. MicroRNAs-208b-3p, 204-5p, 129-2-3p and 3065-5p as predictive markers of oral leukoplakia that progress to cancer. Am J Cancer Res. 2016;6:1537-46.

PMid:27508095

12. Harrandah AM, Fitzpatrick SG, Smith MH, Wang DR, Cohen DM, Chan EKL. MicroRNA-375 as a biomarker for malignant transformation in oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122:743-752.

https://doi.org/10.1016/j.oooo.2016.07.022

PMid:27720656 

13. Brito JA, Gomes CC, Guimarães AL, Campos K, Gomez RS. Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. J Oral Pathol Med. 2014;43:211-6.

https://doi.org/10.1111/jop.12112

PMid:24020903 

14. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, Galloni NN, et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet. 2009;18:4818-29.

https://doi.org/10.1093/hmg/ddp446

PMid:19776030 

15. Xie NN, Liu ZX, Wu C, Wang PL, Song GT, Chen Z. MicroRNA-200c suppresses tumor metastasis in oral squamous carcinoma by inhibiting epithelial-mesenchymal transition. Eur Rev Med Pharmacol Sci. 2018;22:3415-22.

PMid:29917193

16. Li D, Liu K, Li Z, Wang J, Wang X. miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells. Cell Adh Migr. 2018;12:236-46.

https://doi.org/10.1080/19336918.2017.1365992

PMid:29130787 PMCid:PMC6149514

17. Zeng G, Xun W, Wei K, Yang Y, Shen H. MicroRNA-27a-3p regulates epithelial to mesenchymal transition via targeting YAP1 in oral squamous cell carcinoma cells. Oncol Rep. 2016;36:1475-82.

https://doi.org/10.3892/or.2016.4916

PMid:27432214 

18. Lin Z, Sun L, Chen W, Liu B, Wang Y, Fan S, et al. miR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1. Cancer Sci. 2014;105:1288-98.

https://doi.org/10.1111/cas.12499

PMid:25130698 PMCid:PMC4462345

19. Xiao W, Bao ZX, Zhang CY, Zhang XY, Shi LJ, Zhou ZT, et al. Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia. Plos One. 2012;7:e38648.

https://doi.org/10.1371/journal.pone.0038648

PMid:22719913 PMCid:PMC3377716

20. Hashiguchi Y, Kawano S, Goto Y, Yasuda K, Kaneko N, Sakamoto T, et al. Tumor-suppressive roles of ΔNp63β-miR-205 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma via targeting ZEB1 and ZEB2. J Cell Physiol. 2018;233:6565-77.

https://doi.org/10.1002/jcp.26267

PMid:29150940 PMCid:PMC6055661

21. Wang X, Guo H, Yao B, Helms J. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer. Oncol Rep. 2017;37:2720-6.

https://doi.org/10.3892/or.2017.5532

PMid:28350138 

22. Qiao B, He BX, Cai JH, Tao Q, King-Yin Lam A. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1. Sci Rep. 2017;7:44688.

https://doi.org/10.1038/srep44688

PMid:28425477 PMCid:PMC5397903

23. Lin XJ, He CL, Sun T, Duan XJ, Sun Y, Xiong SJ. hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma. Int J Mol Med. 2017;40:83-9.

https://doi.org/10.3892/ijmm.2017.2992

PMid:28535002 PMCid:PMC5466395

24. Liu X, Wang C, Chen Z, Jin Y, Wang Y, Kolokythas A, et al. MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. Biochem J. 2011;440:23-31.

https://doi.org/10.1042/BJ20111006

PMid:21770894 PMCid:PMC3331719

25. Zeng B, Li Y, Jiang F, Wei C, Chen G, Zhang W, et al. LncRNA GAS5 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis. Exp Cell Res. 2019;374:365-73.

https://doi.org/10.1016/j.yexcr.2018.12.014

PMid:30576678 

26. Chen H, Liu X, Jin Z, Gou C, Liang M, Cui L, et al. A three miRNAs signature for predicting the transformation of oral leukoplakia to oral squamous cell carcinoma. Am J Cancer Res. 2018;8:1403-13.

PMid:30210912

27. Maimaiti A, Abudoukeremu K, Tie L, Pan Y, Li X. MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia. Gene. 2015;558:271-7.

https://doi.org/10.1016/j.gene.2015.01.004

PMid:25576219 

28. Chattopadhyay E, Singh R, Ray A, Roy R, De Sarkar N, Paul RR, et al. Expression deregulation of mir31 and CXCL12 in two types of oral precancers and cancer: importance in progression of precancer and cancer. Sci Rep. 2016;6:32735.

https://doi.org/10.1038/srep32735

PMid:27597234 PMCid:PMC5011738

29. Liu Y, Zeng S, Jiang X, Lai D, Su Z. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer. Tumour Biol. 2017;39:1010428317694539.

https://doi.org/10.1177/1010428317694539

PMid:28466783 

30. Liu Y, Cui L, Huang J, Ji EH, Chen W, Messadi D, et al. SOX4 Promotes Progression in OLP-Associated Squamous Cell Carcinoma. J Cancer. 2016;7:1534-40.

https://doi.org/10.7150/jca.15689

PMid:27471569 PMCid:PMC4964137

31. Cheng YD, Zhang XL, Li P, Yang CD, Tang JY, Deng XH, et al. MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK. Oncotargets Ther. 2016;9:5091-9.

https://doi.org/10.2147/OTT.S101067

PMid:27574450 PMCid:PMC4993393

32. Fang C, Li Y. Prospective applications of microRNAs in oral cancer. Oncol Lett. 2019;18:3974-84.

https://doi.org/10.3892/ol.2019.10751

PMid:31579085

33. Setien-Olarra A, Gainza-Cirauqui ML, Aguirre-Urizar JM, Marichalar-Mendia X. The role of microRNAs in oral lichenoid disorders. Systematic review. Med Oral Patol Oral Cir Bucal. 2017;22:e548-e53.

https://doi.org/10.4317/medoral.21819

PMid:28809371 PMCid:PMC5694176

34. Solomon MC, Radhakrishnan RA. MicroRNA's - The vibrant performers in the oral cancer scenario. Jpn Dent Sci Rev. 2020;56:85-9.

https://doi.org/10.1016/j.jdsr.2020.04.001

PMid:32612717 PMCid:PMC7310692

35. Cai Y, Yu X, Hu S, Yu J. A Brief Review on the Mechanisms of miRNA Regulation. Genomics Proteomics Bioinformatics. 2009;7:147-54.

https://doi.org/10.1016/S1672-0229(08)60044-3

PMid:20172487

36. Roy R, Singh R, Chattopadhyay E, Ray A, Sarkar N, Aich R, et al. MicroRNA and target gene expression based clustering of oral cancer, precancer and normal tissues. Gene. 2016;593:58-63.

https://doi.org/10.1016/j.gene.2016.08.011

PMid:27515006 

37. El-Sakka H, Kujan O, Farah CS. Assessing miRNAs profile expression as a risk stratification biomarker in oral potentially malignant disorders: A systematic review. Oral Oncol. 2018;77:57-82.

https://doi.org/10.1016/j.oraloncology.2017.11.021

PMid:29362128 

38. Yap T, Koo K, Cheng L, Vella LJ, Hill AF, Reynolds E, et al. Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls. Cancer Prevention Research. 2018;11:491-502.

https://doi.org/10.1158/1940-6207.CAPR-17-0409

PMid:29764807 

39. Yap T, Seers C, Koo K, Cheng L, Vella LJ, Hill AF, et al. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders. Oral Oncol. 2019;96:113-20.

https://doi.org/10.1016/j.oraloncology.2019.07.013

PMid:31422202 

40. Villa A, Celentano A, Glurich I, Borgnakke WS, Jensen SB, Peterson DE, et al. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies. Oral Dis. 2019;25:64-78.

https://doi.org/10.1111/odi.13087

PMid:31140698 PMCid:PMC6544170